75.95
1.88 (2.54%)
Previous Close | 74.07 |
Open | 73.83 |
Volume | 3,180,093 |
Avg. Volume (3M) | 5,141,293 |
Market Cap | 34,776,363,008 |
Price / Earnings (TTM) | 15.96 |
Price / Earnings (Forward) | 18.18 |
Price / Sales | 1.72 |
Price / Book | 3.69 |
52 Weeks Range | |
Earnings Date | 31 Jul 2025 - 14 Aug 2025 |
TTM Dividend Yield | 0.17% |
Profit Margin | 11.03% |
Operating Margin (TTM) | 14.78% |
Diluted EPS (TTM) | 4.76 |
Quarterly Revenue Growth (YOY) | 2.70% |
Quarterly Earnings Growth (YOY) | 50.80% |
Total Debt/Equity (MRQ) | 97.51% |
Current Ratio (MRQ) | 0.980 |
Operating Cash Flow (TTM) | 1.78 B |
Levered Free Cash Flow (TTM) | 1.58 B |
Return on Assets (TTM) | 5.87% |
Return on Equity (TTM) | 26.44% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Bearish | Mixed |
Health Information Services (Global) | Bearish | Mixed | |
Stock | GE HealthCare Technologies Inc. | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | -0.5 |
Insider Activity | NA |
Price Volatility | 2.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 2.0 |
Average | 0.88 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%). |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Mid Core |
% Held by Insiders | 0.28% |
% Held by Institutions | 80.65% |
52 Weeks Range | ||
Price Target Range | ||
High | 89.00 (Wells Fargo, 17.18%) | Buy |
Median | 85.00 (11.92%) | |
Low | 73.00 (UBS, -3.88%) | Hold |
Average | 83.00 (9.28%) | |
Total | 5 Buy, 2 Hold | |
Avg. Price @ Call | 67.81 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Morgan Stanley | 06 May 2025 | 78.00 (2.70%) | Hold | 67.09 |
UBS | 05 May 2025 | 73.00 (-3.88%) | Hold | 69.37 |
Evercore ISI Group | 01 May 2025 | 85.00 (11.92%) | Buy | 67.67 |
Goldman Sachs | 01 May 2025 | 82.00 (7.97%) | Buy | 67.67 |
Wells Fargo | 01 May 2025 | 89.00 (17.18%) | Buy | 67.67 |
Citigroup | 30 Apr 2025 | 86.00 (13.23%) | Buy | 70.33 |
Piper Sandler | 23 Apr 2025 | 88.00 (15.87%) | Buy | 64.89 |
No data within this time range.
TTM Dividend Yield | 0.17% |
2Y Average Dividend Yield | 0.13% |
Payout Ratio | 2.63% |
Expected Next Dividend Payment | Nov 2025 |
Ex Date | Announcement Date | Payment Date | Details |
---|---|---|---|
25 Apr 2025 | 27 Mar 2025 | 15 May 2025 | 0.035 Cash |
14 Jan 2025 | 21 Nov 2024 | 14 Feb 2025 | 0.035 Cash |
18 Oct 2024 | 18 Sep 2024 | 15 Nov 2024 | 0.03 Cash |
19 Jul 2024 | 26 Jun 2024 | 15 Aug 2024 | 0.03 Cash |
18 Apr 2024 | 22 Mar 2024 | 15 May 2024 | 0.03 Cash |
12 Jan 2024 | 08 Dec 2023 | 15 Feb 2024 | 0.03 Cash |
19 Oct 2023 | 22 Sep 2023 | 15 Nov 2023 | 0.03 Cash |
20 Jul 2023 | 23 Jun 2023 | 15 Aug 2023 | 0.03 Cash |
22 May 2023 | 25 Apr 2023 | 15 Jun 2023 | 0.03 Cash |
Annual Dividend Yield
Year | Annual Dividend ($) | Frequency/Year | Yield % |
---|---|---|---|
2025 | 0.070 | 2 | 0.09 |
2024 | 0.120 | 4 | 0.15 |
2023 | 0.090 | 3 | 0.12 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |